lunes, 25 de septiembre de 2023
20-I-0160—Dose-Escalation Study of a Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model
https://www.niaid.nih.gov/clinical-trials/20-i-0160-dose-escalation-study-low-pathogenicity-avian-h10n7-influenza-virus?utm_medium=social&utm_source=govdelivery&utm_campaign=clinicaltrail_influenzavirus_9252023 NIAID is enrolling healthy, nonsmoking adults 18-50 years of age for an inpatient flu study. The study is being conducted by NIAID and will take place at the National Institutes of Health Clinical Center in Bethesda, MD. There is no cost to participate and compensation may be provided.